Unlike female breast cancer, male breast cancer (MBC) is rare and not very well understood.
Prospective data in the management of MBC are lacking and majority of treatment strategies …

National Comprehensive Cancer Network (NCCN) guidelines for female breast cancer
treatment and surveillance are well established, but similar guidelines on male breast …

Diagnosis and treatment modalities for female breast cancer have developed spectacularly
in recent years. Unfortunately, this is not the case for male breast cancer. Because the …

Male breast cancer accounts for around 1% of all breast cancer cases, but the incidence has
increased over the past 25years. The rarity of this entity precludes prospective randomized …

Male breast cancer is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Most data on male breast cancer comes from small single-institution …

Purpose: To retrospectively evaluate the 15-year experience with breast cancer in males at
a single institution. Methods: The data from 25 male patients who had undergone surgery for …

Male breast cancer (BC) represents less than 1% of male tumors. Little is known about male
BC characteristics, management, and survival, with many studies based on a small number …

Introduction Male breast carcinoma (MBC) is treated similarly to female breast carcinoma
(FBC), and similar survival rates for both have been assumed. We analyzed prognostic and …

Incidence of male breast carcinoma (MBC), although rare, recently has an increasing trend.
The increase in incidence is associated with increasing age, and poor clinical outcome seen …

BACKGROUND: Infiltrating MBC represents less than 1% of all male cancers. Our study
details clinico-pathological features, treatments and prognostic factors in a large French …